Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Adds Type 2 diabetes as a study topic and MedlinePlus Genetics as a related topic, with the page revision updated to v3.6.5. Removes the sponsor AstraZeneca and certain external links (Clinical Study Results on trialsummaries.com and Helpful Links Provided by) along with the older revision tag v3.6.4.
    Difference
    0.4%
    Check dated 2026-08-13T11:39:35.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page footer displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor release or template update applied to the study page without altering the study data.
    Difference
    0.0%
    Check dated 2026-07-23T08:33:55.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now lists Type 2 diabetes as a related topic and adds MedlinePlus Genetics as a related topics resource, clarifying the study's subject area and linking to related genetic information. These additions help users understand the study's focus and access associated genetics resources.
    Difference
    0.2%
    Check dated 2026-07-09T05:21:33.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new page revision tag Revision: v3.6.3 has been added. The condition label 'Type 2 diabetes' and the related topics 'MedlinePlus Genetics' were removed, and the older revision tag Revision: v3.6.1 was dropped.
    Difference
    0.2%
    Check dated 2026-07-02T03:13:37.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision tag at the bottom of the page updated from v3.6.0 to v3.6.1, indicating a newer build of the page. This update does not alter study data, eligibility criteria, or how the page functions.
    Difference
    0.0%
    Check dated 2026-06-24T23:47:11.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The study page now shows that recruitment is closed and no participants are being sought. New help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, along with a revision note (Revision: v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-16T20:26:22.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.